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Synthetic Procedures.
Butadiene sulfone (1) (4.15 g, 35.2 mmol) and ketone 2b (10.3 g, 35.2 mmol) were dissolved in tetrahydrofuran (200 mL), and the solution was cooled to 78 ºC. LiHMDS (42.3 mL, 1 M in tetrahydrofuran, 42.3 mmol) was added in one portion. The reaction mixture was stirred for 1 h at 78 ºC, then removed from the cooling bath and stirred 1 h at room temperature. The reaction was quenched by the addition of 10% aqueous HCl (50 mL), and the mixture was 
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Compound 4b (crude, 14.5 g, 35.2 mmol) was dissolved in tetrahydrofuran (400 mL), and the solution was cooled to 78 ºC. LiHMDS (42.3 mL, 1 M in tetrahydrofuran, 42.3 mmol) was added in one portion. The reaction mixture was stirred for 30 min at 78 ºC then removed from the cooling bath and stirred 2.5 h at room temperature. The reaction was quenched by the addition of saturated aqueous NH 4 Cl and the mixture was partially concentrated in vacuo. The resulting red solution was partitioned between saturated aqueous NH 4 Cl and dichloromethane.
The organic fraction was washed with brine, dried with Na 2 SO 4 and concentrated in vacuo at 30 ºC to provide 14.5 g of crude vinyl sulfone 5b as a brick red solid. 
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Compound 5b (crude, 5.01 g, 12.5 mmol) was dissolved in tetrahydrofuran (200 mL). The solution was cooled to 0 ºC and Red-Al (5.7 mL, 65% in toluene, 18.5 mmol) was added in one portion. The solution was stirred at 0 ºC for 45 min. An aqueous 10% solution of Rochelle's salt was added in small portions over 5 min until gas evolution desisted. The reaction mixture was partitioned between ethyl acetate and water. The organic fraction was dried with Na 2 SO 4
and concentrated in vacuo. Flash-column chromatography (dichloromethane:ethyl acetate 25:1) afforded 1.33 g (26% over 3 steps from 1) of sulfone 6. IR (film) 3477 (br), 1250, 1108 cm -1 ;
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Compound 6 (1.33 g, 3.21 mmol) was dissolved in dichloromethane (80 mL). The solution was cooled to 78 ºC, then ozone was bubbled through until a light blue color persisted. The solution was purged with argon for 10 min, then dimethylsulfide (3.21 mL) was added at 78
ºC. The reaction mixture was warmed to room temperature and stirred for 16 h. The reaction mixture was concentrated in vacuo, and the crude product was carried on to the next step with no further purification. The crude aldehyde was dissolved in t-butanol (16 mL), tetrahydrofuran (8 mL) and water (8 mL). KH 2 PO 4 (2.2 g, 16 mmol) was added, followed by 2-methyl-2-butene (1.7 mL, 16 mmol). The reaction mixture was stirred for 5 min, then sodium chlorite (725 mg, 
S9
Compound 8 (151 mg, 0.380 mmol) was dissolved in methanol (8 mL). Acetic acid (~ 100 µL) was added, followed by Pd/C 10% (~ 10 mg). The reaction mixture was pressurized inside a Parr reactor to 300 PSI of H 2 and was stirred for 16 h. The reaction mixture was filtered through cotton, diluted with cyclohexane (10 mL) then concentrated in vacuo to provide 111 mg of the acetic acid salt of amine 8a as a white solid. Compound 8b (54 mg, 0.094 mmol) was dissolved in methanol (5 mL). Acetic acid (~ 100 µL) and 10% aqueous HCl (~ 50 µL) was added, followed by Pd/C 10% (~10 mg). The reaction mixture was stirred inside a Parr reactor pressurized to 300 PSI H 2 and was stirred for 16 h. The reaction mixture was filtered through cotton, diluted with cyclohexane (10 mL) then concentrated in vacuo to provide 29 mg (90%) of the hydrochloride salt of 10, ethyl ester.
Prior to biological testing the compound was purified through recrystallization from methanol and dichloromethane. 
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Compound 11 (5.90 g, 12.5 mmol) was dissolved in 200 mL acetone. N-Methylmorpholine-Noxide (2.92 g, 25 mmol) was added, followed by OsO 4 (4.0 mL, 4% in water, 0.625 mmol). NaHCO 3 . The aqueous layer was washed with ethyl acetate, and the combined organic extracts were dried with Na 2 SO 4 and concentrated in vacuo to provide 2.21 g of a 12a as a white solid.
The crude product was carried to the next step with no further purification.
Compound 12a (2.21 g, 6.53 mmol) was dissolved in 40 mL pyridine. The solution was cooled to 0 o C, then methanesulfonyl chloride (1.02 mL, 13.06 mmol) was added. The solution was stirred at room temperature for 16 h. The reaction mixture was concentrated in vacuo, then partitioned between dichloromethane and water. The aqueous layer was washed with ethyl acetate, and the combined organic extracts were dried with Na 2 SO 4 and concentrated in vacuo.
The crude mesylate (2.72 g, 6.53 mmol) was dissolved in 25 mL dimethylformamide. NaN 3
(1.27 g, 19.6 mmol) was added. The reaction mixture was heated at 60 
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Compound 14 (crude, 130 mg, 0.429 mmol) was dissolved in dimethylformamide (6 mL).
Triethylamine (300 µL, 2.14 mmol) was added, followed by HgCl 2 
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Compound 14a (50 mg, 0.085 mmol) was dissolved in methanol (8 mL). Acetic acid (~ 100 µL) and 10% aqueous HCl (~ 50 µL was added, followed by Pd/C 10% (~ 10 mg). All enzyme assays were conducted on a SpectraMax M5 platereader using standard sensitivity settings. The following solutions were prepared for the enzyme assays:
1. Assay Buffer: 50 mM Tris, 5 mM CaCl 2 , 200 mM NaCl, pH 7.5; For kinetic data, the working solution was subjected to serial dilution to obtain a range of substrate concentrations. Progress of the reaction was measured over 10 min at various concentrations of substrate and inhibitor, as indicated in Figure 5 . Control experiments (substrate buffer only) showed no significant background reaction.
Protein Stock
IC 50 values were obtained by plotting percent inhibition against inhibitor concentration using XLfit (IDBS software) and identifying the concentration required to achieve 50% inhibition of 
